Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1985 May;60(2):427–436.

Plasma membrane antigens on light density and activated human blood eosinophils.

P C Tai, D M Bakes, J R Barkans, C J Spry
PMCID: PMC1577022  PMID: 4006306

Abstract

In order to study the membrane events which lead to human blood eosinophil activation and degranulation, six clone of mouse monoclonal antibodies were made to isolated blood eosinophils from a patient with the hypereosinophilic syndrome (HES). The antibodies were specific for the plasma membranes of blood eosinophils and neutrophils, eosinophil myelocytes and haemopoietic cell lines. A higher proportion of blood eosinophils from eight patients with the HES bound these antibodies compared to normal individuals. Five antibodies stained intermediate density eosinophils preferentially, and one stained the light density eosinophils most strongly. Normal blood eosinophils were induced to express more of these antigens either by culture alone (two antibodies) or culture with monocyte culture supernatant which activates eosinophils for increased cytotoxic capacity (four antibodies). It was concluded that several of the principal antigens on the eosinophil plasma membrane are also present on neutrophils and immature haemopoietic cells, and that their expression in mature blood eosinophils is related to the extent of eosinophil activation and degranulation. It is suggested that these antigens may be useful in studying the ways in which eosinophils alter their plasma membrane during activation and degranulation in vitro, and in the blood of patients with an eosinophilia.

Full text

PDF
427

Images in this article

430Fig. 1
on p.430

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ACKERMAN G. A. EOSINOPHILIC LEUKEMIA: A MORPHOLOGIC AND HISTOCHEMICAL STUDY. Blood. 1964 Oct;24:372–388. [PubMed] [Google Scholar]
  2. Anwar A. R., Kay A. B. Membrane receptors for IgG and complement (C4, C3b and C3d) on human eosinophils and neutrophils and their relation to eosinophilia. J Immunol. 1977 Sep;119(3):976–982. [PubMed] [Google Scholar]
  3. Capron M., Capron A., Dessaint J. P., Torpier G., Johansson S. G., Prin L. Fc receptors for IgE on human and rat eosinophils. J Immunol. 1981 Jun;126(6):2087–2092. [PubMed] [Google Scholar]
  4. De Simone C., Donelli G., Meli D., Molinari A., Rosati F., Sorice F. Human peripheral eosinophils with receptors for IgM: demonstration and ultrastructural morphology. Immunobiology. 1982;162(2):116–127. doi: 10.1016/S0171-2985(11)80023-9. [DOI] [PubMed] [Google Scholar]
  5. De Simone C., Donneli G., Meli D., Rosati F., Sorice F. Human eosinophils and parasitic diseases. II. Characterization of two cell fractions isolated at different densities. Clin Exp Immunol. 1982 Apr;48(1):249–255. [PMC free article] [PubMed] [Google Scholar]
  6. Dessein A. J., Lenzi H. L., Bina J. C., Carvalho E. M., Weiser W. Y., Andrade Z. A., David J. R. Modulation of eosinophil cytotoxicity by blood mononuclear cells from healthy subjects and patients with chronic schistosomiasis mansoni. Cell Immunol. 1984 Apr 15;85(1):100–113. doi: 10.1016/0008-8749(84)90282-x. [DOI] [PubMed] [Google Scholar]
  7. Flaum M. A., Schooley R. T., Fauci A. S., Gralnick H. R. A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. I. Hematologic manifestations. Blood. 1981 Nov;58(5):1012–1020. [PubMed] [Google Scholar]
  8. Galfre G., Howe S. C., Milstein C., Butcher G. W., Howard J. C. Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature. 1977 Apr 7;266(5602):550–552. doi: 10.1038/266550a0. [DOI] [PubMed] [Google Scholar]
  9. Goers J. W., Glovsky M. M., Hunkapiller M. W., Farnsworth V., Richards J. H. Studies on C3ahu binding to human eosinophils: characterization of binding. Int Arch Allergy Appl Immunol. 1984;74(2):147–151. doi: 10.1159/000233535. [DOI] [PubMed] [Google Scholar]
  10. Griffin J. D., Ritz J., Nadler L. M., Schlossman S. F. Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J Clin Invest. 1981 Oct;68(4):932–941. doi: 10.1172/JCI110348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. López A. F., Vadas M. A. Stimulation of human granulocyte function by monoclonal antibody WEM-G1. Proc Natl Acad Sci U S A. 1984 Mar;81(6):1818–1821. doi: 10.1073/pnas.81.6.1818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mahmoud A. A., Kellermeyer R. W., Warren K. S. Production of monospecific rabbit antihuman eosinophil serums and demonstration of a blocking phenomenon. N Engl J Med. 1974 Feb 21;290(8):417–420. doi: 10.1056/NEJM197402212900801. [DOI] [PubMed] [Google Scholar]
  13. Mason D. Y., Sammons R. Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents. J Clin Pathol. 1978 May;31(5):454–460. doi: 10.1136/jcp.31.5.454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Prin L., Capron M., Tonnel A. B., Bletry O., Capron A. Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia. Int Arch Allergy Appl Immunol. 1983;72(4):336–346. doi: 10.1159/000234893. [DOI] [PubMed] [Google Scholar]
  15. Prin L., Charon J., Capron M., Gosset P., Taelman H., Tonnel A. B., Capron A. Heterogeneity of human eosinophils. II. Variability of respiratory burst activity related to cell density. Clin Exp Immunol. 1984 Sep;57(3):735–742. [PMC free article] [PubMed] [Google Scholar]
  16. Spry C. J., Davies J., Tai P. C., Olsen E. G., Oakley C. M., Goodwin J. F. Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med. 1983 Winter;52(205):1–22. [PubMed] [Google Scholar]
  17. Spry C. J., Tai P. C. Studies on blood eosinophils. II. Patients with Löffler's cardiomyopathy. Clin Exp Immunol. 1976 Jun;24(3):423–434. [PMC free article] [PubMed] [Google Scholar]
  18. Spry C. J. The hypereosinophilic syndrome: clinical features, laboratory findings and treatment. Allergy. 1982 Nov;37(8):539–551. doi: 10.1111/j.1398-9995.1982.tb02339.x. [DOI] [PubMed] [Google Scholar]
  19. Tai P. C., Spry C. J. Enzymes altering the binding capacity of human blood eosinophils for IgG antibody-coated erythrocytes (EA). Clin Exp Immunol. 1980 Apr;40(1):206–219. [PMC free article] [PubMed] [Google Scholar]
  20. Tai P. C., Spry C. J., Peterson C., Venge P., Olsson I. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature. 1984 May 10;309(5964):182–184. doi: 10.1038/309182a0. [DOI] [PubMed] [Google Scholar]
  21. Tai P. C., Spry C. J. The mechanisms which produce vacuolated and degranulated eosinophils. Br J Haematol. 1981 Oct;49(2):219–226. doi: 10.1111/j.1365-2141.1981.tb07218.x. [DOI] [PubMed] [Google Scholar]
  22. Taniyama T., Tokunaga T. Monoclonal antibodies directed against mouse macrophages in different stages of activation for tumor cytotoxicity. J Immunol. 1983 Aug;131(2):1032–1037. [PubMed] [Google Scholar]
  23. Thorne K. J., Franks D. Surface proteins of the human eosinophil. I. Isolation of eosinophil IgG binding proteins. Clin Exp Immunol. 1984 May;56(2):464–472. [PMC free article] [PubMed] [Google Scholar]
  24. Thorne K. J., Free J., Franks D., Oliver R. C. The mechanism of Fc-mediated interaction of eosinophils with immobilized immune complexes. II. Identification of two membrane proteins, modified by the interaction. J Cell Sci. 1982 Aug;56:357–369. doi: 10.1242/jcs.56.1.357. [DOI] [PubMed] [Google Scholar]
  25. Thorne K. J., Oliver R. C., Glauert A. M. Eosinophil interaction with antibody-coated, non-phagocytosable surfaces: changes in cell surface proteins. J Cell Sci. 1980 Apr;42:367–378. doi: 10.1242/jcs.42.1.367. [DOI] [PubMed] [Google Scholar]
  26. Thorne K. J., Oliver R. C., Glauert A. M. Eosinophil membrane changes during interaction with antibody-coated non-phagocytosable surfaces. Biochem Soc Trans. 1981 Feb;9(1):71–71. doi: 10.1042/bst0090071. [DOI] [PubMed] [Google Scholar]
  27. Thorne K. J., Richardson B. A., Butterworth A. E. Surface proteins of the human eosinophil. II. Effects of Schistosoma mansoni larvae on eosinophil surface proteins. Clin Exp Immunol. 1984 Jun;56(3):577–583. [PMC free article] [PubMed] [Google Scholar]
  28. Vadas M. A., David J. R., Butterworth A., Pisani N. T., Siongok T. A. A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni. J Immunol. 1979 Apr;122(4):1228–1236. [PubMed] [Google Scholar]
  29. Vadas M. A., Nicola N., Lopez A. F., Metcalf D., Johnson G., Pereira A. Mononuclear cell-mediated enhancement of granulocyte function in man. J Immunol. 1984 Jul;133(1):202–207. [PubMed] [Google Scholar]
  30. Veith M. C., Butterworth A. E. Enhancement of human eosinophil-mediated killing of Schistosoma mansoni larvae by mononuclear cell products in vitro. J Exp Med. 1983 Jun 1;157(6):1828–1843. doi: 10.1084/jem.157.6.1828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Veith M., Taylor D. W., Thorne K., Richardson B. A., Butterworth A. E. Studies on the enhancement of human eosinophil function by mononuclear cell products in vitro. Clin Exp Immunol. 1984 Dec;58(3):603–610. [PMC free article] [PubMed] [Google Scholar]
  32. Winqvist I., Olofsson T., Olsson I., Persson A. M., Hallberg T. Altered density, metabolism and surface receptors of eosinophils in eosinophilia. Immunology. 1982 Nov;47(3):531–539. [PMC free article] [PubMed] [Google Scholar]
  33. Zola H., McNamara P., Thomas M., Smart I. J., Bradley J. The preparation and properties of monoclonal antibodies against human granulocyte membrane antigens. Br J Haematol. 1981 Jul;48(3):481–490. doi: 10.1111/j.1365-2141.1981.tb02740.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES